The squamous cell lung carcinomas showed two cases with ARID1A loss of function variants (E1718* and G1848fs), one FGFR3 S249C variant, one MAP2K1 P124L, and one case with PIK3CA amplification and E545A variant. This evidence concerns the gene MAP2K1 and squamous cell lung carcinoma.